Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation
2018
Opportunities and challenges in the development of kinase inhibitor therapy for cancer
2003
Platelet Derived Growth Factor Expression, Myelofibrosis and Chronic Myelogenous Leukemia
1995
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Neurological Complications of the Leukemias Across the Ages
2017
The FGF family: biology, pathophysiology and therapy
2009 Standout
Effects of temperature, time, and solvent ratio on the extraction of phenolic compounds and the anti-radical activity of Clinacanthus nutans Lindau leaves by response surface methodology
2017 Standout
Clinacanthus nutans : A review of the medicinal uses, pharmacology and phytochemistry
2016 Standout
Molecular monitoring of BCR–ABL as a guide to clinical management in chronic myeloid leukaemia
2005
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Genetic instabilities in human cancers
1998 StandoutNature
Role of antioxidants in cancer therapy
2012
Systematic review of amifostine for the management of oral mucositis in cancer patients
2012
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Dynamics of chronic myeloid leukaemia
2005 Nature
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Silencing of Suppressor of Cytokine Signaling-3 due to Methylation Results in Phosphorylation of STAT3 in Imatinib Resistant BCR-ABL Positive Chronic Myeloid Leukemia Cells
2014
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Ethnobotanical survey of usage of fresh medicinal plants in Singapore
2014 Standout
Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances?
1996
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
2005 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
2007
Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation
1993
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care
2008
Clinacanthus nutansExtracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines
2013 Standout
Extraction of phytocompounds from the medicinal plant Clinacanthus nutans Lindau by microwave-assisted extraction and supercritical carbon dioxide extraction
2015 Standout
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
2004
Interventions for preventing oral mucositis for patients with cancer receiving treatment
2011
Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms
1990
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics
2003
Combination therapy in combating cancer
2017 Standout
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
2008
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
2006
How I treat transfusional iron overload
2012
Interventions for treating oral mucositis for patients with cancer receiving treatment
2010
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Drug Resistance in Cancer: An Overview
2014 Standout
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML
2004
New Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance
2006
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of K Taylor being referenced
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
2005
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
2012
Central nervous system prophylaxis in haematological malignancies
2002
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
1988
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
2003
Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses.
1987